Contract signed with second leading CRO

AI SummaryClose X

Trellus Health plc (AIM: TRLS) announced a 12-month contract with a second major global clinical research organisation to deploy its Trellus TrialSetâ„¢ offering, commencing before year-end. This agreement, structured with an upfront fee, monthly management fee, and milestone payments, will support recruitment and enrolment optimisation for two late-stage immunology and inflammation clinical trials. While this marks a strategic growth area and validates their offering, the company explicitly stated the contract does not immediately extend its cash runway beyond early December 2025. Trellus Health continues to explore options for a potential equity fundraising, a critical factor for investors given the short cash runway.

Disclaimer*

UK 100

Latest directors dealings